Biology
Cellular Mechanisms of Skeletal Muscle Hypertrophy and Atrophy
Quick fact
The loss of muscle mass during just 2-3 weeks of bed rest can be as high as 10-15% in elderly individuals, largely due to the activation of the ubiquitin-proteasome protein degradation pathway.
Why this is interesting
You’ve probably heard that lifting weights builds muscle and that bed rest can cause muscle to shrink. But have you ever wondered what's actually happening inside your muscle cells that makes them grow bigger or waste away?
Read the full explanation
Understanding Cellular Mechanisms of Skeletal Muscle Hypertrophy and Atrophy
Think of your muscle cells as factories that constantly produce and break down proteins. When you exercise, especially with resistance training, your muscles experience mechanical tension. This tension acts like a signal that tells the factory to increase production of contractile proteins. The key player inside the cell is a signaling molecule called mTOR, which acts like a foreman, ramping up protein synthesis. Simultaneously, the factory also has a demolition crew—the ubiquitin-proteasome system—that tags and degrades worn-out proteins. Normally, these two processes are in balance. When you train, you shift the balance toward synthesis, leading to hypertrophy. When you don't use your muscles, such as during injury or a sedentary lifestyle, the signal for synthesis weakens, and the demolition crew becomes more active, breaking down proteins faster than they're made. This leads to atrophy. So muscle size is a tug-of-war between building and breaking down proteins.
A deeper explanation
At the molecular level, muscle hypertrophy is driven by the IGF-1/AKT/mTOR pathway. Mechanical force activates IGF-1, which triggers a cascade resulting in the phosphorylation of AKT. Active AKT then activates mTOR, which phosphorylates downstream targets like p70S6K and 4E-BP1, leading to increased translation of muscle-specific proteins. AKT also inhibits the activity of FoxO transcription factors, which would otherwise promote the expression of atrophy-related genes. Atrophy, on the other hand, is often mediated by pro-inflammatory cytokines like TNF-alpha and myostatin, which activate FoxO. FoxO upregulates the expression of E3 ubiquitin ligases, such as MAFbx/atrogin-1 and MuRF-1, which tag muscle proteins for degradation by the proteasome. Additionally, autophagy is induced, which degrades organelles and protein aggregates. Muscle satellite cells also contribute to hypertrophy by fusing with existing myofibers to provide new nuclei and supporting protein synthesis. Understanding these signaling networks is crucial because they are the targets for therapeutic interventions to prevent muscle wasting in conditions like cancer cachexia, sarcopenia, and spaceflight-related atrophy.